Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Conly

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Annals of Internal Medicine|November 28, 2022
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers : A Randomized TrialMark Loeb, Amy Bartholomew, Madiha Hashmi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal ProductionPeter J Collignon, John M Conly, Antoine Andremont, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Antimicrobial Resistance and Infection Control|April 19, 2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018Wallis Rudnick, John Conly, Daniel J G Thirion, et al.
CMAJ Open|December 22, 2021
The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional surveyGreg J German, Charles Frenette, Jean-Alexandre Caissy, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
Antimicrobial Resistance and Infection Control|February 15, 2020
Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016Wallis Rudnick, Michelle Science, Daniel J G Thirion, et al.
Emerging Infectious Diseases|July 22, 2022
Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, CanadaCasey R J Hubert, Nicole Acosta, Barbara J M Waddell, et al.
Journal of Medical Virology|December 29, 2022
Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaksNicole Acosta, Maria A Bautista, Barbara J Waddell, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Annals of Internal Medicine|November 28, 2022
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers : A Randomized TrialMark Loeb, Amy Bartholomew, Madiha Hashmi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal ProductionPeter J Collignon, John M Conly, Antoine Andremont, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Antimicrobial Resistance and Infection Control|April 19, 2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018Wallis Rudnick, John Conly, Daniel J G Thirion, et al.
CMAJ Open|December 22, 2021
The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional surveyGreg J German, Charles Frenette, Jean-Alexandre Caissy, et al.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
Antimicrobial Resistance and Infection Control|February 15, 2020
Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016Wallis Rudnick, Michelle Science, Daniel J G Thirion, et al.
Emerging Infectious Diseases|July 22, 2022
Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, CanadaCasey R J Hubert, Nicole Acosta, Barbara J M Waddell, et al.
Journal of Medical Virology|December 29, 2022
Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaksNicole Acosta, Maria A Bautista, Barbara J Waddell, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
Pageof 12